SAMRAT PHARMACHEM LTD. Share Price

SAMRAT PHARMACHEM LTD. Share Price

BSE: 530125
|
Pharmaceuticals
|
S Cap
₹ 227.00
-₹7.70 (-3.28%)
1D
Last updated 02 Sep, 2026, 15:29 IST

SAMRAT PHARMACHEM LTD. Share Price Today

As of 3 Sep 2026, SAMRAT PHARMACHEM LTD. share price is ₹227.00. The stock opened at ₹231.25, compared to its previous close of ₹234.70. During today's trading session, SAMRAT PHARMACHEM LTD. share price moved in the range of ₹225.00 to ₹234.70, with an average price of ₹229.85 for the day. Looking at its last 52-week, the stock has touched a low of ₹190.00 and a high of ₹333.00.

₹225.00
3.28% down today
₹234.70
1D LOW
1D HIGH

SAMRAT PHARMACHEM LTD. Returns Calculator

Circuit
L
H
₹216.65
₹239.45
52-week
L
H
₹190.00
₹333.00

About SAMRAT PHARMACHEM LTD.

SAMRAT PHARMACHEM LTD. Share Price
ISIN
INE103E01016
Sector Market Cap
₹ 70.46 Cr

Samrat Pharmachem Limited is an India-based manufacturer of iodine salts. The Company is engaged in the business of pharmaceutical chemicals. Its products include 3-5 Di Iodosalicylic Acid, Ammonium Iodide, Cadmium Iodide, Calcium Iodate, Clioquinol, Copper Iodide, Ethyl Iodide, Ethylenediamine Dihydroiodide, Hydroiodic Acid 57%, Iodine, Iodine Monochloride, Iodine Monochloride, Iodoquinol, Methyl Iodide, N-Iodo Succinimide, Periodic Acid, Potassium Iodate, Potassium Iodide, Potassium Metaper Iodate, Povidone Iodine, Selenium Dioxide, Sodium Iodate, Sodium Iodide, Sodium Metaper Iodate. These products are offered for the agrochemical, animal feed, chemical, cosmetics, food, pharmaceutical, painting and textile industries. The Company exports its products to geographics such as the United States, Europe, Africa, Asia, the Middle East and others.

SAMRAT PHARMACHEM LTD. Financial Highlights

  • Revenue: SAMRAT PHARMACHEM LTD. reported revenue of ₹290.55 crore in FY26 vs ₹286.83 crore in FY25. It showed an increase of 1.30% on a yearly basis.
  • Operating Profit: SAMRAT PHARMACHEM LTD. reported an operating loss of ₹2.98 crore in FY26 vs ₹9.89 crore in FY25. It showed a decrease of 130.13% on a year-on-year basis.
  • Net Profit: SAMRAT PHARMACHEM LTD. reported a net loss of ₹3.31 crore in FY26 vs ₹7.11 crore in FY25. It showed a decrease of 146.55% on a yearly basis.

SAMRAT PHARMACHEM LTD. Quarterly Result Highlights

  • SAMRAT PHARMACHEM LTD. reported revenue of ₹80.75 crore in Jun 2026, compared with ₹71.46 crore in Mar 2026, representing an increase of 13.00% on a quarter-on-quarter (QoQ) basis.
  • SAMRAT PHARMACHEM LTD. reported an operating profit of ₹1.59 crore in Jun 2026, compared with ₹1.87 crore in Mar 2026, representing an increase of 185.03% on a quarter-on-quarter (QoQ) basis.
  • SAMRAT PHARMACHEM LTD. reported a profit of ₹0.88 crore in Jun 2026, compared with ₹2.04 crore in Mar 2026, reflecting an increase of 143.14% on a QoQ basis.
  • The earnings per share (EPS) of SAMRAT PHARMACHEM LTD. stood at ₹10.72 during Jun 2026.
Know more
Promoters
49.09%
FII
3.24%
Other DII
0.00%
Retail and other
47.67%
Mutual funds
0.00%
Foreign institutions - FII
FII shareholding by period
Sep 20253.24%
Dec 20253.24%
Mar 20263.24%
Jun 20263.24%
Mkt Cap Cr
70.46
P/E
-31.94
P/B
1.03
ROE
-4.86%
D/E
0.16
ROCE
-2.57%
Div. Yield
0.00%
EPS(TTM)
-10.72
Turnover
2.36
EV/EBITDA
-335.78
Net Margin
-1.14%
Op. Margin
-0.45%
ROA
-1.78%
Quick Ratio
1.08
Curr. Ratio
2.30
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Samrat Pharma has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Samrat Pharma appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,63,180.0038.285.5513.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,43,302.0083.7914.6215.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,88,623.0088.2922.6425.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,16,114.0025.004.2418.59%0.3117.35%237.300.09%0.3335.38
Cipla1,14,554.0034.023.3211.27%0.0014.95%423.360.92%0.4543.52
Laurus Labs1,00,660.0092.3218.9916.77%0.4016.14%97.200.11%0.6713.72
Lupin98,312.2017.734.3823.76%0.0424.88%659.000.84%0.57129.18
Dr. Reddy's Laboratories96,906.3030.442.5511.07%0.1812.54%377.950.69%0.4138.68
Mankind Pharma97,467.0047.546.0311.74%0.3413.13%397.020.04%0.4449.37
Aurobindo Pharma96,836.1025.682.529.25%0.1911.76%394.820.24%0.3841.58

SAMRAT PHARMACHEM LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹289.72₹285.86₹281.58₹310.65
Other Income₹0.83₹0.97₹1.38₹0.48
Total Revenue₹290.55₹286.83₹282.97₹311.12
Total Expenses₹293.54₹276.95₹280.45₹288.59
Profit Before Tax-₹2.98₹9.89₹2.52₹22.53
Tax₹0.33₹2.77₹0.36₹5.90
Profit After Tax-₹3.31₹7.11₹2.16₹16.63
EPS - Basic-₹10.72₹23.02₹7.00₹53.83
EPS - Diluted-₹10.72₹23.02₹7.00₹53.83

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹2.98₹9.89₹2.52₹22.53
Income before WC changes-₹1.89₹10.53₹2.55₹24.18
Change in Assets₹5.91-₹10.01-₹5.75-₹32.20
Change in Liabilities₹6.39-₹9.16₹15.58₹8.09
Change in WC₹12.30-₹19.17₹9.83-₹24.12
Cash flow from Operations₹8.88-₹10.09₹9.41-₹9.44
Cash flow from Investing-₹2.57₹0.00-₹0.41-₹3.00
Cash flow from Financing-₹0.47₹0.48-₹11.20₹9.60
Total Cash Flow₹5.83-₹9.62-₹2.19-₹2.84
Cash (Start of the year)₹0.05₹9.67₹11.86₹14.71
Cash (End of the year)₹5.88₹0.05₹9.67₹11.86

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹20.63₹18.13₹19.17₹17.54
Current Assets₹103.79₹103.36₹102.57₹99.05
Total Assets₹124.42₹121.49₹121.74₹116.59
Current Liabilities₹55.82₹49.58₹56.40₹53.19
Net Current Asset₹47.96₹53.78₹46.16₹45.86
Non-Current Liabilities₹0.41₹0.11₹0.34₹0.25
Equity Capital₹68.18₹71.80₹65.00₹63.14
Total Equity & Liabilities₹124.42₹121.49₹121.74₹116.59
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
1
Neutral
3
Bullish
4
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
39.95
Neutral
ATR (14)
11.31
Neutral
STOCH(9,6)
10.18
Bullish
STOCH RSI (14)
0.69
Bullish
ADX(9)
16.71
Bullish
UO(9)
48.75
Neutral
ROC(12)
-0.55
Bearish
WillR(14)
-89.82
Bullish
Period
Simple value
Exponential vaue
5D
238.01
235.52
10D
239.57
237.86
20D
240.22
239.87
50D
244.55
238.46
100D
228.52
232.56
Volume trend — traded volume by day
2 Sep0L
1 Sep0L
31 Aug0L
28 Aug0L
27 Aug0L
Average0L
Compare against other stocks
SAMRAT PHARMACHEM LTD. Share Price
SAMRAT PHARMACHEM LTD.
Pharmaceuticals
Add Stock
Add Another

SAMRAT PHARMACHEM LTD. Share Price FAQs